颧种植体治疗严重牙齿缺失及上颌骨缺损的15年回顾性评估
该回顾性研究分析了27例严重牙齿缺失患者接受颧种植体(ZI)治疗的数据,评估其疗效与安全性。患者平均年龄22.63岁,共植入85枚ZI和42枚常规种植体(CI)。ZI早期存活率100%,粗存活率在种植体水平为98.5%,患者水平为96.3%。结论认为ZI可作为严重少牙或无牙患者的治疗选择。
要点
- ZI在严重牙齿缺失患者中早期存活率达100%,粗存活率种植体水平98.5%。
- 主要并发症包括上颌窦浑浊和种植体周围软组织退缩。
- ZI联合常规种植体或Quad Zygoma术式可用于严重上颌骨缺损重建。
核心结论
- ZI可作为严重少牙或无牙患者的治疗选择,研究支持其可行性和良好结局。
研究设计与样本
- 回顾性研究,纳入27例严重少牙或无牙患者,年龄18-37岁(平均22.63岁),其中20例伴综合征。
- 共植入85枚ZI和42枚CI,平均随访55.07个月(范围13.27-179.2个月)。
主要发现
- 所有ZI均实现成功骨结合,早期存活率100%。
- ZI和CI粗存活率在种植体水平分别为98.5%(84/85)和76.19%(32/42),患者水平分别为96.3%(26/27)和64.71%(11/17)。
- ZI主要并发症为上颌窦浑浊和种植体周围软组织退缩。
临床怎么用
- 对严重少牙或无牙伴上颌骨缺损患者,可考虑ZI联合常规种植体或Quad Zygoma术式。
- 术前需综合影像学、基因检测和多学科会诊制定个性化方案。
局限性
- 回顾性设计,样本量较小(27例),随访时间范围差异大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This retrospective study analyzed the clinical data of 27 patients with severe tooth agenesis who underwent zygomatic implants (ZIs) over the past 15 years, with an aim of evaluating the efficacy and safety of ZIs in patients with severe oligodontia and anodontia. MATERIALS AND METHODS: Patients who were diagnosed with severe oligodontia or anodontia and treated with ZI were included. All the patients received comprehensive preoperative assessments, including radiographic imaging, genetic testing, and multidisciplinary consultations to develop customized treatment plans. The treatment strategies primarily involved extensive bone grafting combined with multiple conventional implants (CIs) and a single ZI approach or the Quad Zygoma approach. Postoperative rehabilitation involved immediate or delayed loading with provisional prostheses, followed by definitive full-arch implant-supported restorations. RESULTS: Twenty-seven patients with 20 patients exhibiting syndromes, aged 18-37 years (mean age 22.63), were enrolled. A total of 85 ZIs and 42 CIs were placed in the maxilla. All the ZIs achieved successful osseointegration, yielding an early survival rate of 100%. The crude survival rates of ZIs and CIs were 98.5% (84/85) and 76.19% (32/42) at the implant level and 96.3% (26/27) and 64.71% (11/17) at the patient level, respectively, with a mean follow-up of 55.07 months (range: 13.27-179.2 months). The main complications associated with ZIs included maxillary sinus opacification and peri-implant soft-tissue recession. CONCLUSIONS: ZIs could be a treatment option for patients with severe oligodontia and anodontia. This study may support the feasibility and favorable outcomes of ZIs in the management of severe tooth agenesis.
引用
- Tao B, Wang F, Shen Y, et al. Retrospective Evaluation of Zygomatic Implant Therapy in Patients With Severe Tooth Agenesis and Maxillary Deficiencies: Clinical Outcomes and Safety up to 15 Years of Follow-Up. Clin Oral Implants Res. 2026. PMID: 42740365. doi:10.1111/clr.70174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。